this article discusses the changing epidemiology clinical and laboratory diagnosis pathogenesis and treatment of cdi.microbiologyc difficile is an obligate anaerobic spore-forming gram-positive rod first described in 1935 as bacillus difficilis in the fecal flora of healthy infants.1 the organism remained unrecognized as a cause of human infection until 1977 when it was identified as the cause of what had previously been referred to as antibiotic-associated colitis.23 hall and o'toole's1 species name reflected difficulty of isolating c difficile from otherthis article is an update of an article previously published in clinics in laboratory medicine volume 30 issue 1 march 2010.disclosure statement the author has nothing to disclose.division of infectious diseases medical university of south carolina 1215 rutledge tower 135 rutledge avenue msc 752 charleston sc 29425 usae-mail address clin lab med 37 2017 341-369labmed.theclinics.com0272-271217a 2017 elsevier inc. all rights reserved.

clostridium difficile scott r. curry mdoverviewclostridium difficile was identified as the leading cause of antibiotic-associated diar- rhea and colitis in 1978 but since 2001 c difficile infections cdis have evolved from sporadic complications of antimicrobial therapy to severe sometimes fatal events that have become an endemic threat to the health of hospitalized and immuno- suppressed patients worldwide.

